ID DYR3_SALTM Reviewed; 162 AA. AC P12833; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1989, sequence version 1. DT 03-MAY-2023, entry version 101. DE RecName: Full=Dihydrofolate reductase type 3; DE EC=1.5.1.3; DE AltName: Full=Dihydrofolate reductase type III; GN Name=dhfrIII; OS Salmonella typhimurium. OG Plasmid pAZ1. OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Salmonella. OX NCBI_TaxID=90371; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2840679; DOI=10.1016/0147-619x(88)90060-1; RA Fling M.E., Kopf J., Richards C.; RT "Characterization of plasmid pAZ1 and the type III dihydrofolate reductase RT gene."; RL Plasmid 19:30-38(1988). RN [2] RP PROTEIN SEQUENCE OF 1-21. RX PubMed=6371010; DOI=10.1016/s0021-9258(18)91094-x; RA Joyner S.S., Fling M.E., Stone D., Baccanari D.P.; RT "Characterization of an R-plasmid dihydrofolate reductase with a monomeric RT structure."; RL J. Biol. Chem. 259:5851-5856(1984). CC -!- FUNCTION: Key enzyme in folate metabolism. Catalyzes an essential CC reaction for de novo glycine and purine synthesis, and for DNA CC precursor synthesis (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(6S)-5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + CC H(+) + NADPH; Xref=Rhea:RHEA:15009, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57451, ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349; EC=1.5.1.3; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00660}; CC -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8- CC tetrahydrofolate from 7,8-dihydrofolate: step 1/1. CC -!- SUBUNIT: Monomer. CC -!- MISCELLANEOUS: The plasmid pAZ1 determines trimethoprim and CC sulphonamide resistance. CC -!- SIMILARITY: Belongs to the dihydrofolate reductase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J03306; AAA25550.1; -; Genomic_DNA. DR PIR; B22241; B22241. DR PIR; JT0266; RDEBDT. DR AlphaFoldDB; P12833; -. DR SMR; P12833; -. DR KEGG; ag:AAA25550; -. DR UniPathway; UPA00077; UER00158. DR GO; GO:0004146; F:dihydrofolate reductase activity; IEA:UniProtKB-EC. DR GO; GO:0050661; F:NADP binding; IEA:InterPro. DR GO; GO:0006545; P:glycine biosynthetic process; IEA:InterPro. DR GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW. DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW. DR GO; GO:0031427; P:response to methotrexate; IEA:UniProtKB-KW. DR GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:UniProtKB-UniPathway. DR CDD; cd00209; DHFR; 1. DR Gene3D; 3.40.430.10; Dihydrofolate Reductase, subunit A; 1. DR InterPro; IPR012259; DHFR. DR InterPro; IPR024072; DHFR-like_dom_sf. DR InterPro; IPR017925; DHFR_CS. DR InterPro; IPR001796; DHFR_dom. DR PANTHER; PTHR48069; DIHYDROFOLATE REDUCTASE; 1. DR PANTHER; PTHR48069:SF3; DIHYDROFOLATE REDUCTASE; 1. DR Pfam; PF00186; DHFR_1; 1. DR PIRSF; PIRSF000194; DHFR; 1. DR PRINTS; PR00070; DHFR. DR SUPFAM; SSF53597; Dihydrofolate reductase-like; 1. DR PROSITE; PS00075; DHFR_1; 1. DR PROSITE; PS51330; DHFR_2; 1. PE 1: Evidence at protein level; KW Antibiotic resistance; Direct protein sequencing; Methotrexate resistance; KW NADP; One-carbon metabolism; Oxidoreductase; Plasmid; KW Trimethoprim resistance. FT CHAIN 1..162 FT /note="Dihydrofolate reductase type 3" FT /id="PRO_0000186421" FT DOMAIN 2..160 FT /note="DHFR" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00660" FT CONFLICT 8 FT /note="A -> S (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 162 AA; 18033 MW; 199343AE8675FDED CRC64; MLISLIAALA HNNLIGKDNL IPWHLPADLR HFKAVTLGKP VVMGRRTFES IGRPLPGRRN VVVSRNPQWQ AEGVEVAPSL DAALALLTDC EEAMIIGGGQ LYAEALPRAD RLYLTYIDAQ LNGDTHFPDY LSLGWQELER STHPADDKNS YACEFVTLSR QR //